About Peptiboon Prasit
Form D filings for Genesis Therapeutics from 2020 to 2023 list Peptiboon Prasit as executive officer and director.
Peptiboon Prasit first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Peptiboon Prasit in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Peptiboon Prasit works with at each company, as listed on that company's latest Form D.
Genesis Therapeutics, Inc. · Form D, Aug 25, 2023
VP
Vijay Pande
Director
EF
Evan Feinberg
PRESIDENT and CEO, director
WM
William Mccarthy
Executive officer
LB
Leonard Bell
Director
KJ
Kris Jenner
Director
BS
Benjamin Sklaroff
Executive officer